Top

Virology Journal

Published in:

Open Access 01-12-2010 | Short report

Molecular characterization of hepatitis A virus isolates from environmental and clinical samples in Greece

Authors: Petros Kokkinos, Panos Ziros, Sevasti Filippidou, Ioannis Mpampounakis, Apostolos Vantarakis

Published in: Virology Journal | Issue 1/2010

Abstract

Background

Hepatitis A virus (HAV) strains detected in environmental and clinical samples were analysed to characterize the genotypes of HAV circulating in Greece. Fifty (50) sewage samples were collected from Patras (South-Western Greece) and Alexandroupolis (North-Eastern Greece) from 2007 until 2009, accordingly. The clinical samples derived from an HAV outbreak involved populations from three neighbouring prefectures of North-Eastern Greece (Xanthi, Rodopi, and Evros). HAV particles were detected by nested RT-PCR, using a previously validated set of primers to amplify a 290-bp fragment encompassing the 5'-NTR. Positive HAV samples were confirmed by sequencing of the PCR product. To determine the relatedness between the different isolated sequences, a phylogenetic tree was constructed.

Results

Results showed a 100% prevalence of genotype I, and particularly subgenotype IA. The analyzed HAV strains were closely related between them with the percentage of nucleotide identity ranging between 96% and 100%.

Conclusions

The study revealed the major prevalence of circulating strains of IA genotype in Greece and underlined the usefulness of molecular methods for the detection and typing of viruses in both environmental and clinical samples. The present study is, to our knowledge, the first in Greece to depict the simultaneous molecular characterization of HAV strains isolated from both clinical and environmental samples.

Available only for authorised users

Sánchez G, Populaire S, Butot S, Putallaz T, Joosten H: Detection and differentiation of human hepatitis A strains by commercial quantitative real-time RT-PCR tests. J Virol Methods 2006, 132: 160-165. 10.1016/j.jviromet.2005.10.010PubMedCrossRef

Dounias G, Rachiotis G: Prevalence of hepatitis A virus infection among municipal solid-waste workers. Int J Clin Pract 2006, 60: 1432-1436. 10.1111/j.1742-1241.2006.00845.xPubMedCrossRef

Rodrigues L, Pista A, Oliveira A, Agua-Doce I, Manita C, Paixão MT: Molecular epidemiology of hepatitis A virus in a group of Portuguese citizens living in Lisbon area. J Med Virol 2007, 79: 483-487. 10.1002/jmv.20851PubMedCrossRef

Kwon OS, Byun KS, Yeon JE, Park SH, Kim JS, Kim JH, Bak YT, Kim JH, Lee CH: Detection of hepatitis A viral RNA in sera of patients with acute hepatitis A. J Gastroenterol Hepatol 2000, 15: 1043-1047. 10.1046/j.1440-1746.2000.02291.xPubMedCrossRef

Arvanitidou M, Mamassi P, Vayona A: Epidemiological evidence for vaccinating wastewater treatment plant workers against hepatitis A and hepatitis B virus. Eur J Epidemiol 2004, 19: 259-262. 10.1023/B:EJEP.0000020444.64546.3bPubMedCrossRef

Pintó RM, Alegre D, Domínguez A, El-Senousy WM, Sánchez G, Villena C, Costafreda MI, Aragonès L, Bosch A: Hepatitis A virus in urban sewage from two Mediterranean countries. Epidemiol Infect 2007, 135: 270-273. 10.1017/S0950268806006753PubMedPubMedCentralCrossRef

Mazokopakis E, Vlachonikolis J, Philalithis A, Lionis C: Seroprevalence of hepatitis A, B and C markers in Greek warship personnel. Eur J Epidemiol 2000, 16: 1069-1072. 10.1023/A:1010857128629PubMedCrossRef

Kyrka A, Tragiannidis A, Cassimos D, Pantelaki K, Tzoufi M, Mavrokosta M, Pedeli X, Athanassiadou F, Hatzimichael A, Konstantopoulos A, Kafetzis D, Papaevangelou V: Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination. J Med Virol 2009, 81: 582-587. 10.1002/jmv.21434PubMedCrossRef

Vantarakis A, Nearxou A, Pagonidis D, Melegos F, Seretidis J, Kokkinos P, Zarkadis I, Parasidis T, Alamanos Y: An outbreak of hepatitis A in Roma populations living in three prefectures in Greece. Epidemiol Infect 2010, 138: 1025-1031. 10.1017/S0950268809991257PubMedCrossRef

10.

Kokkinos P, Filippidou S, Karlou K, Vantarakis A: Molecular Typing of Enteroviruses, Adenoviruses, and Hepatitis A Viruses in Untreated and Treated Sewage of a Biological Treatment Plant in Greece. Food Environ Virol 2010, 2: 89-96. 10.1007/s12560-010-9036-3CrossRef

11.

Pina S, Buti M, Jardí R, Clemente-Casares P, Jofre J, Girones R: Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J Gen Virol 2001, 82: 2955-2963.PubMedCrossRef

12.

Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos T, Petridou ET: Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece. J Med Virol 2008, 80: 791-797. 10.1002/jmv.21134PubMedCrossRef

13.

Gabrieli R, Sanchez G, Macaluso A, Cenko F, Bino S, Palombi L, Buonomo E, Pinto RM Bosch A, Divizia M: Hepatitis in Albanian children: Molecular analysis of hepatitis A virus isolates. J Med Virol 2004, 72: 533-537. 10.1002/jmv.20028PubMedCrossRef

14.

Divizia M, Gabrieli R, Macaluso A, Bagnato B, Palombi L, Buonomo E, Cenko F, Leno L, Bino S, Basha A, Panà A: Nucleotide correlation between HAV isolates from human patients and environmental samples. J Med Virol 2005, 75: 8-12. 10.1002/jmv.20229PubMedCrossRef

15.

Gharbi-Khelifi H, Sdiri K, Harrath R, Fki L, Hakim H, Berthomé M, Billaudel S, Ferre V, Aouni M: Genetic analysis of HAV strains in Tunisia reveals two new antigenic variants. Virus Genes 2007,35(2):155-159. 10.1007/s11262-007-0093-0PubMedCrossRef

Title: Molecular characterization of hepatitis A virus isolates from environmental and clinical samples in Greece
Authors: Petros Kokkinos
Panos Ziros
Sevasti Filippidou
Ioannis Mpampounakis
Apostolos Vantarakis
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-7-235

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E

CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected Female sex workers

Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule

A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats

Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes

Concentration of acrylamide in a polyacrylamide gel affects VP4 gene coding assignment of group A equine rotavirus strains with P[12] specificity

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials